Philip R. Debruyne, MD, PhD, MSc, DABCP (CP), FRCP(Glasg, Lon), FCP is a specialised doctor in general (internal) medicine, pharmacology and medical oncology at the OECI-designated Kortrijk Cancer Centre of az groeninge (Kortrijk, Belgium; since 2008). His clinical specialty interests are: gynaecological & urological cancers and early phase clinical trials. Since 2016 he serves as an honorary visiting professor of Anglia Ruskin University (Centre for Biomedical Research and Health Innovation, School of Life Sciences, Cambridge, UK) and since 2021 as an honorary clinical professor of cancer pharmacology at the School of Nursing and Midwifery (Faculty of Health) of the University of Plymouth, UK. His research interests include supportive cancer care and geriatric oncology.
AZ Groeninge
Kortrijk, Belgium
OECI-designated Kortrijk Cancer Centre
Anglia Ruskin University
Cambridge, Cambridgeshire, UK
School of Allied Health and Social Care
University of Plymouth
Plymouth, UK
School of Nursing and Midwifery
The two-year Merck Sharp & Dohme International Fellowship in Clinical Pharmacology Award (2002-2004)
Merck and Co., Rahway, USA
International 2-year scholarship to fund training in the USA
5th Pfizer Oncology Award 2020
Pfizer (Belgium), Brussels, Belgium
Award to fund innovative project in the field of QoL